Tuberculosis - Pipeline Review, H1 2015

1
Tuberculosis - Pipeline Review, H1 2015
2
Report Description
Tuberculosis - Pipeline Review, H1
2015 Summary Tuberculosis - Pipeline Review, H1
2015, provides an overview of the Tuberculosiss
therapeutic pipeline. This report provides
comprehensive information on the therapeutic
development for Tuberculosis, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Tuberculosis and special features
on late-stage and discontinued projects. Get
complete Report _at_ http//www.bigmarketresearch.co
m/tuberculosis-pipeline-review-h1-2015-market
3
Report Description
The report features investigational drugs from
across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built
using data and information sourced from Global
Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. The report enhances decision
making capabilities and help to create effective
counter strategies to gain competitive advantage.
It strengthens RD pipelines by identifying new
targets and MOAs to produce first-in-class and
best-in-class products. Note Certain sections
in the report may be removed or altered based on
the availability and relevance of data for the
indicated disease. Enquire About this report _at_
http//www.bigmarketresearch.com/report-enquiry/31
6385
4
Report Description
Scope - The report provides a snapshot of the
global therapeutic landscape of Tuberculosis -
The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players
involved in the therapeutics development for
Tuberculosis and enlists all their major and
minor projects - The report summarizes all the
dormant and discontinued pipeline projects - A
review of the Tuberculosis products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources - Pipeline
products coverage based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages - A detailed
assessment of monotherapy and combination therapy
pipeline projects - Coverage of the Tuberculosis
pipeline on the basis of target, MoA, route of
administration and molecule type - Latest news
and deals relating related to pipeline products
5
Report Description
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Tuberculosis - Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline - Devise corrective
measures for pipeline projects by understanding
Tuberculosis pipeline depth and focus of
Indication therapeutics - Develop and design
in-licensing and out-licensing strategies by
identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline
6
Table of Contents
Table Of Contents Table of Contents
2 Introduction 6 Tuberculosis Overview
7 Therapeutics Development 8 Tuberculosis -
Therapeutics under Development by Companies
10 Tuberculosis - Therapeutics under
Investigation by Universities/Institutes
16 Tuberculosis - Pipeline Products Glance
21 Tuberculosis - Products under Development by
Companies 25 Tuberculosis - Products under
Investigation by Universities/Institutes
32 Tuberculosis - Companies Involved in
Therapeutics Development 37 Tuberculosis -
Therapeutics Assessment 94 Drug Profiles
105 Tuberculosis - Recent Pipeline Updates
307 Tuberculosis - Dormant Projects
325 Tuberculosis - Discontinued Products
331 Tuberculosis - Product Development Milestones
332 Appendix 340
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/tuberculosis-pipe
line-review-h1-2015-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States